Bioidentical vs Synthetic Hormones: What the Evidence Actually Shows

The question of bioidentical versus synthetic hormones is one of the most common sources of confusion in hormone replacement therapy. Patients have heard the terms used in marketing, in popular books, on podcasts, and in conversations between friends. Each source seems to define the terms slightly differently. Some treat bioidentical as automatically safer and synthetic as outdated and dangerous. Others dismiss the distinction entirely as marketing language that does not reflect real clinical differences. Neither extreme is accurate.

This article walks through what bioidentical and synthetic hormones actually are, the meaningful clinical differences between them, where the evidence is strong and where it is overstated, and how to think about which is right for your situation. The goal is to give you the framework to evaluate hormone therapy options honestly — without the marketing on one side and without the dismissal on the other.

What “bioidentical” actually means

Bioidentical hormones are hormones that are molecularly identical to the hormones the human body produces. When a chemist looks at the molecular structure of estradiol made by a pharmaceutical company or compounding pharmacy and compares it to estradiol produced by a human ovary, the molecules are indistinguishable. Same atoms, same bonds, same configuration.

The major bioidentical hormones used in clinical practice include:

• Estradiol — the primary form of estrogen produced by the ovaries during reproductive years
• Progesterone — the hormone produced by the corpus luteum and during pregnancy
• Testosterone — the primary androgen produced in significant quantities in men and in smaller quantities in women
• DHEA — a precursor hormone produced by the adrenal glands
• Cortisol and others used in specific clinical situations

Bioidentical hormones can be produced two ways. FDA-approved bioidentical products are manufactured by pharmaceutical companies under standard FDA approval and quality control processes. Estrogen patches like Climara and Vivelle-Dot, estradiol gels and creams, oral micronized progesterone (Prometrium), and testosterone preparations like Androgel and Testopel are all bioidentical and FDA-approved. Compounded bioidentical hormones are produced by licensed compounding pharmacies and are typically prescribed when a specific dose or formulation that is not available as an FDA-approved product is clinically appropriate.

Both forms are bioidentical. Both are clinically legitimate. The difference is in the regulatory pathway and the customization options, not in the molecule itself.

What “synthetic” means in this context

The word “synthetic” causes some of the confusion in this conversation because it has two different meanings.

In one sense, all pharmaceutical hormones are “synthetic” because they are manufactured in laboratories rather than extracted from natural sources. Bioidentical estradiol made by a pharmaceutical company is synthesized — it is just synthesized to be molecularly identical to natural estradiol.

In the more common patient-facing sense, “synthetic hormones” refers specifically to hormones that have a molecular structure different from human hormones but produce similar biological effects. The classic examples are:

• Conjugated equine estrogens (CEE), sold as Premarin, derived from pregnant mare urine. This is a mixture of estrogenic compounds, most of which do not exist in the human body.
• Medroxyprogesterone acetate (MPA), sold as Provera, a synthetic progestin with progesterone-like effects but a different molecular structure than human progesterone.
• Ethinyl estradiol, the synthetic estrogen used in most birth control pills, which has a different structure than natural estradiol.
• Various other progestins (norethindrone, norgestimate, drospirenone, levonorgestrel) used in contraceptives and some hormone replacement protocols.

These molecules do bind to the same receptors that natural hormones bind to, and they do produce biological effects that are similar in many respects. But the molecular differences mean the body processes them differently, the metabolic byproducts are different, and the side effect profile can be different from bioidentical equivalents.

The clinical differences that actually matter

The clinical evidence for differences between bioidentical and synthetic hormones is uneven across categories. Some differences are well-established. Others are debated. Others are marketing claims that do not hold up under scrutiny.

The clearest differences emerge in two specific comparisons.

Bioidentical progesterone vs synthetic progestins. This is where the evidence for differences is strongest. Synthetic progestins like medroxyprogesterone acetate have been associated with worse outcomes than bioidentical progesterone in several important areas — breast cancer risk in women on combination hormone therapy, cardiovascular risk markers, mood and sleep effects, and metabolic profile. The Women’s Health Initiative study that drove the 2002 hormone therapy backlash used conjugated equine estrogens plus medroxyprogesterone acetate — a synthetic-synthetic combination that produces a different risk profile than bioidentical estradiol plus bioidentical progesterone. Modern practice generally prefers bioidentical micronized progesterone (typically Prometrium or compounded equivalents) over synthetic progestins for hormone replacement, partly because the evidence on differential outcomes is meaningful.

Oral vs transdermal estrogen. This is technically a delivery route distinction rather than a bioidentical vs synthetic distinction, but it intersects in important ways. Oral estrogen — whether bioidentical estradiol or synthetic preparations like CEE — passes through the liver before reaching systemic circulation. This first-pass hepatic effect produces increased clotting factor production, which raises venous thromboembolism risk and certain cardiovascular risk markers. Transdermal estrogen — patches, gels — bypasses the liver and has a more favorable cardiovascular and clotting risk profile. Modern practice generally prefers transdermal estradiol for these reasons, particularly in women with cardiovascular risk factors or any history of clotting issues.

For testosterone replacement in men, the bioidentical question is somewhat different. Testosterone cypionate, testosterone enanthate, and the testosterone in pellets and gels are all bioidentical — they are testosterone molecules. The distinctions in male hormone optimization are more about delivery route, dosing strategy, and ancillary medications than about bioidentical vs synthetic. Our TRT page covers this in more detail.

Where the bioidentical claim is overstated

Some of the popular framing around bioidentical hormones overstates the case. A few points worth being honest about:

Bioidentical is not synonymous with “safer in every way.” Bioidentical hormones still have the same fundamental risks as the hormones the body produces — endometrial effects in women without progesterone protection, breast tissue effects, cardiovascular effects, metabolic effects. The risks are not eliminated by molecular identity. They are modulated, sometimes meaningfully, but not removed.

Compounded bioidentical hormones are not automatically better than FDA-approved bioidenticals. Some clinics promote compounded bioidenticals as if they were uniquely effective. In reality, FDA-approved bioidentical products are typically the first choice when they fit the clinical need, because they have rigorous manufacturing quality controls and well-characterized pharmacokinetics. Compounded bioidenticals are appropriate when a specific dose or formulation not available as FDA-approved is clinically needed — they are tools, not magic.

“Natural” is a marketing word, not a clinical category. Some clinics describe bioidentical hormones as “natural,” implying they are extracted from natural sources. Most bioidentical hormones used clinically are synthesized in pharmaceutical manufacturing facilities. The molecule is identical to what the body produces, but the production is industrial. This is not a problem clinically — bioidentical estradiol made in a lab works the same as bioidentical estradiol produced by an ovary — but the “natural” framing is marketing.

Saliva testing and customized “compounded protocols” are sometimes oversold. Some clinics promote elaborate protocols built on saliva hormone testing and highly customized compounded preparations, presenting them as superior to standard practice. The evidence for saliva testing as a basis for hormone dosing is weak — blood testing is the clinical standard for good reasons. Customized compounded protocols may be appropriate in specific clinical situations, but they are not automatically better than standard protocols with FDA-approved products.

A clinic that recognizes both the legitimate clinical value of bioidenticals and the limits of the marketing claims is operating at a higher level of clinical literacy than one that uncritically promotes either position.

How modern hormone therapy is typically prescribed

The current standard of care in hormone replacement, in practice, looks something like this:

For women in perimenopause and menopause: Bioidentical estradiol delivered transdermally (patch or gel) for systemic estrogen, paired with oral micronized progesterone (Prometrium or compounded bioidentical equivalent) when uterine protection is needed. Testosterone for women — typically in small physiologic doses, much lower than male TRT — when indicated for libido, energy, or body composition. The doses are individualized based on labs, symptoms, and clinical context. The delivery route is chosen based on the patient’s cardiovascular risk profile, preferences, and response.

For men with low testosterone: Bioidentical testosterone (cypionate or enanthate most commonly) delivered through injection — typically twice weekly in modern practice rather than the every-two-weeks schedule of older protocols. Gel or pellet delivery as alternatives for specific patients. Ancillary medications (HCG for fertility preservation, anastrozole for elevated estradiol response) as clinically indicated.

This standard reflects the integration of bioidentical preference, delivery route optimization, and individualized dosing that has developed over the past two decades of hormone therapy practice. At The Tide, this is the framework we work within — defaulting to FDA-approved bioidenticals where they fit, using compounded preparations when the specific patient need calls for it, and choosing delivery routes based on the individual rather than the template.

When synthetic preparations are still appropriate

The shift toward bioidentical preference does not mean synthetic hormones are obsolete or harmful. They remain appropriate for specific clinical situations.

Synthetic progestins are sometimes used in patients who do not tolerate oral micronized progesterone, particularly when the sedating effects are problematic. Combination patches that include synthetic progestins can simplify dosing for patients who do better with a single device. Birth control pills with ethinyl estradiol remain the standard for contraception and have specific clinical advantages for that purpose. Hormone preparations used in certain medical conditions — endometriosis, severe heavy menstrual bleeding, gender-affirming care in specific contexts — sometimes call for synthetic options.

The point is not that bioidentical is always right and synthetic is always wrong. The point is that the default has shifted toward bioidentical for hormone replacement in perimenopause and menopause, and the clinician should be able to articulate why a specific patient is being prescribed what they are being prescribed.

What to ask your clinic

Several questions clarify how a clinic approaches the bioidentical question:

What is your default for estrogen, progesterone, and testosterone in hormone replacement? A modern clinic should default to bioidentical estradiol (typically transdermal), bioidentical micronized progesterone (typically oral), and bioidentical testosterone (delivery route depending on patient). If the clinic defaults to CEE, MPA, or synthetic preparations as the standard, they are operating with an older framework.

How do you decide between FDA-approved and compounded bioidenticals? The right answer is “FDA-approved when they fit the clinical need, compounded when a specific dose or formulation not available as FDA-approved is required.” A clinic that uses compounded preparations as the default — including when FDA-approved alternatives would work — is operating with marketing logic rather than clinical logic.

How do you choose delivery routes? For estrogen specifically, the choice between oral and transdermal should be based on the patient’s cardiovascular risk profile, preferences, and response. A clinic that uses one route exclusively without explaining why is operating with limited tools.

What labs do you use for monitoring? Standard practice is serum (blood) testing of hormone levels at baseline and follow-up. Saliva testing is not a clinical standard. A clinic that uses saliva testing as the basis for dosing decisions is operating outside the mainstream of clinical practice.

How do you talk about risks? A thorough clinic discusses the legitimate risks of any hormone therapy — cardiovascular, breast tissue, clotting, and others — and explains how the chosen protocol affects those risks. A clinic that dismisses all risks as marketing scare tactics is overselling. A clinic that emphasizes risks to the point of refusing to prescribe even when therapy is clearly indicated is underselling.

What this means for Houston patients

Houston has a wide range of hormone therapy clinics, and the bioidentical question is a useful lens for evaluating them. The clinics worth working with are typically those that:

Default to bioidentical preparations for hormone replacement, with reasoning that reflects current clinical evidence rather than marketing.

Use FDA-approved products when they fit the clinical need and compounded alternatives when there is a specific clinical reason.

Choose delivery routes based on the patient — transdermal estrogen as default for systemic estrogen replacement, oral micronized progesterone for uterine protection, injectable or pellet testosterone for men based on clinical situation.

Use serum testing as the basis for dosing and monitoring decisions.

Can explain why they prescribe what they prescribe in language that reflects clinical evidence rather than oversimplified marketing.

Acknowledge both the legitimate clinical value of bioidenticals and the limits of the marketing claims around them.

The Tide is one of the Houston clinics that operates within this framework. Our women’s hormone health and men’s hormone health services are built around it.

How to think about your own decision

If you are considering hormone replacement therapy, the bioidentical question is not the only question — but it is one of the questions that helps you evaluate whether a clinic is operating with current clinical thinking. Other questions matter equally: the comprehensiveness of the baseline evaluation, the monitoring schedule, the willingness to individualize, the honest discussion of risks and benefits, and the clinic’s overall approach to your care.

The substance matters more than the label. A clinic that prescribes the right medicine, at the right dose, through the right delivery route, with the right monitoring, is doing the work — whether they call it bioidentical hormone replacement, MHT, HRT, or simply hormone therapy. A clinic that markets aggressively on the bioidentical label but skimps on the evaluation, monitoring, or individualization is leaning on the language without doing the work.

Use the bioidentical question as one filter among several. The clinic you want is the one that takes hormone replacement seriously as clinical medicine — not the one that uses the most attractive vocabulary.

About The Tide

The Tide is a peptide-focused medical clinic in Houston, Texas, located adjacent to the Texas Medical Center. We default to bioidentical hormones for hormone replacement, using FDA-approved products where they fit and compounded preparations when a specific clinical need calls for it. Our women’s hormone health and men’s hormone health services prescribe estrogen and progesterone replacement, testosterone replacement therapy, bioidentical hormones, and hormone pellets based on what each patient actually needs. For deeper reading, see our clinical standards and programs.